Charles River Laboratories International, Inc. ( CRL) - Key Metrics
CRL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $20.20 | -$5.62 | $3 | $1.19 |
| 2025Q3 | $20.42 | $1.11 | $4.34 | $3.62 |
| 2025Q2 | $21 | $1.06 | $4.16 | $3.44 |
| 2025Q1 | $19.42 | $0.50 | $3.39 | $2.22 |
CRL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -9.06 |
| 2025Q3 | ? | 33.59 |
| 2025Q2 | ? | 35.23 |
| 2025Q1 | ? | 77.38 |
CRL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.19% | ? |
| 2025Q4 | 0.58% | ? |
| 2025Q3 | 2.44% | ? |
| 2025Q2 | 2.30% | ? |
| 2025Q1 | 1.43% | ? |
CRL
Price: $179.87
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.71 USD
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 411300
Ebitda: 110.3 millionMarket Capitalization: 7.8 billion